Happiness Biotech Group Limited (the “Company”), an innovative China-based nutraceutical and dietary supplements producer, announced today the pricing of a U.S. underwritten initial public offering ("Offering") of 2,000,000 ordinary shares at a price to the public of $5.50 per share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on October 25, 2019 under the ticker symbol "HAPP."

Hunter Taubman Fischer & Li has joined AIPAC Venture Tech as a host committee member. AIPAC is a renowned bipartisan organization of U.S. citizens committed solely to strengthening, protecting and promoting the U.S.-Israel relationship.